Aetna Launching 2 New Plan Benefit Designs
Aetna announced plans to launch two new plan benefit designs aimed at addressing growing concerns by employers about high-deductible plans, [...]
NPC: CMS Proposed Rule Hinders Value-Based Arrangements
In a letter to the Centers for Medicare and Medicaid Services, the National Pharmaceutical Council (NPC) outlines some key issues [...]
Reminder: ICER Webinar on Cost-Recovery Pricing for COVID-19 Drugs is Tomorrow
The first installment of the Institute for Clinical and Economic Review's (ICER) three-part webinar series on drug pricing models for [...]
Webinar to Highlight Challenges of Value Assessment Amid Pandemic
An upcoming webinar sponsored by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the Innovation and Value Initiative [...]
Datta: CMS Proposal a ‘Grab-bag of Issues’
Sidley Austin LLP's Meena Datta told HealthLeaders that the Centers for Medicare and Medicaid Services' (CMS) latest proposal is a [...]
DRG Offers COVID-19 Resources on Website
DRG has compiled a suite of resources to support life sciences companies amid the COVID-19 pandemic. "We've assembled resources to [...]
Eversana Acquires HVH Precision Analytics to Beef Up Data, Analytics Capabilities
Eversana has acquired HVH Precision Analytics from Havas Health & You in a bid to bolster its data analytics capabilities, [...]
Bach Outlines ‘Gaping’ Loophole in Medicaid Proposal
A Centers for Medicare and Medicaid Services proposal includes a "gaping" loophole through which drugmakers could avoid selling drugs to [...]
Report Spotlights Marketing During COVID-19
A new report from Reuters Events offers guidance for pharmaceutical industry solutions providers looking for fresh insights into marketing strategies [...]
ICER Hosting Series on Drug Pricing During a Pandemic
The Institute for Clinical and Economic Review (ICER) is scheduled to host a three-part series focused on drug pricing during [...]
Report: European Drug Regulatory Network Faces Uncertain, Complex Future
A new strategy produced by European regulators considers future challenges for the European drug regulatory network, The Pink Sheet reports. [...]
ICER Outlines Planned Review of High Cholesterol Treatments
The Institute for Clinical and Economic Review (ICER) in a recently-released document outlines its planned review of high cholesterol treatments. [...]
Panel Discusses Provider Prospective on Value-Based Care for mBC
A recent panel discussion on AJMC's Peer Exchange discusses how providers identify value-based care opportunities for metastatic breast cancer. The [...]
Evidation Looks to Bolster Platform to Include Virtual Treatment
After generating $45 million in investments, Evidation is looking to expand its virtual research platform to include digital interventions and [...]
Gilead CEO: Remdesivir Priced ‘Significantly’ Below Value to Society
Gilead CEO Daniel O'Day told STAT he's confident in the company's pricing decision for the COVID-19 drug remdesivir. "We spent [...]
ICER President: Remdesivir Price was ‘Responsible’ Decisions
The Institute for Clinical and Economic Review's president, Steven Pearson, says Gilead's decision to price its COVID-19 treatment remdesivir at [...]
Oncologists Grapple with Supply Shortages Amid Pandemic, Survey Finds
A new survey found that one of oncologists' biggest concerns amid the COVID-19 pandemic is supply shortages, Specialty Pharmacy Continuum [...]
Proposed Medicaid Changes Aim to Foster Innovative Contracts
The Centers for Medicare and Medicaid Services (CMS) is hoping to encourage greater use of innovative contracting models in a [...]
Cytel Outlines Use of Bayesian Methodologies
A new white paper from Cytel outlines how its statisticians have used Bayesian methodologies in the search for effective COVID-19 [...]
ISPOR Offers Short Courses on Medical Devices, Payment Models
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is offering short courses on medical devices and different payment models [...]
NPC: ‘Ready, aim, fire’ Mentality Detrimental in Health Care
Having a "ready, aim, fire" mentality can prove harmful when sharing health care information, the National Pharmaceutical Council (NPC) writes [...]
Legislation Aims to Prevent Pharma From Price-gouging During Pandemic
Two new bipartisan bills introduced by House Democrats aim to prevent the pharmaceutical industry from engaging in price-gouging on COVID-19 [...]
ISPOR-FDA Summit Transitions to Virtual Event
The International Society for Pharmacoeconomics and Outcomes Research's (ISPOR) announced that the joint ISPOR-FDA Summit 2020, set for Sept. 29, [...]
Cytel Offers On-Demand Access to Webinar on Synethic, External Control Arms
A new on-demand webinar from Cytel offers insights into synthetic and external control arms in clinical trials. The webinar features [...]
Kreis: Challenging Price of Costly CF Drug Not ‘Discrimination’
Maurice Kreis, head of the New Hampshire Office of the Consumer Advocate, says challenging the price of Vertex Pharmaceuticals' cystic [...]